文献速递糖尿病性腺与生殖内分泌

Mitchell-Riley综合征迁延性腹泻与先天性GLP-1缺乏相关

Congenital Glucagon-like Peptide-1 Deficiency in the Pathogenesis of Protracted Diarrhea in Mitchell-Riley Syndrome.
PubMed 文献 · J Clin Endocrinol Metab · 2021-01-01

两例RFX6基因突变所致Mitchell-Riley综合征患儿表现为新生儿糖尿病和迁延性腹泻,血浆GLP-1几乎检测不到且远端肠道和直肠GLP-1免疫染色缺失,超说明书使用利拉鲁肽12个月内腹泻快速改善。

要点

  • Mitchell-Riley综合征迁延性腹泻可能与先天性GLP-1缺乏有关
  • 患儿血浆GLP-1水平几乎检测不到且肠道GLP-1免疫染色缺失
  • 利拉鲁肽超说明书治疗12个月内使难治性腹泻快速改善

核心结论

  • Mitchell-Riley综合征患者存在先天性GLP-1缺乏。
  • 利拉鲁肽的良好反应支持GLP-1参与迁延性腹泻的发病机制并具有潜在治疗用途。

研究设计与样本

  • 两例病例报告描述,在三级儿科医院进行。
  • 两例患儿诊断为Mitchell-Riley综合征,表现为新生儿糖尿病和迁延性腹泻。

主要发现

  • 两例患者血浆GLP-1水平几乎检测不到。
  • 两例患者远端肠道和直肠GLP-1免疫染色缺失。
  • 超说明书利拉鲁肽治疗作为难治性迁延性腹泻的挽救治疗,在12个月内腹泻快速改善。

关键数值与推荐

  • 利拉鲁肽为儿童2型糖尿病获批药物,在本例中为超说明书使用。

临床怎么用

  • 对Mitchell-Riley综合征迁延性腹泻患儿可评估GLP-1水平。
  • GLP-1类似物利拉鲁肽可作为难治性迁延性腹泻的潜在挽救治疗选择。

局限性

  • 仅两例病例报告,证据级别有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Mitchell-Riley syndrome due to RFX6 gene mutations is characterized by neonatal diabetes and protracted diarrhea. The RFX6 gene encodes a transcription factor involved in enteroendocrine cell differentiation required for beta-cell maturation. In contrast to the pathway by which RFX6 mutations leads to diabetes, the mechanisms underlying protracted diarrhea are unknown. OBJECTIVE: To assess whether glucagon-like peptide-1 (GLP-1) was involved in the pathogenesis of Mitchell-Riley syndrome protracted diarrhea. METHODS: Two case report descriptions. in a tertiary pediatric hospital. "Off-label" treatment with liraglutide. We describe 2 children diagnosed with Mitchell-Riley syndrome, presenting neonatal diabetes and protracted diarrhea. Both patients had nearly undetectable GLP-1 plasma levels and absence of GLP-1 immunostaining in distal intestine and rectum. The main outcome was to evaluate whether GLP-1 analogue therapy could improve Mitchell-Riley syndrome protracted diarrhea. RESULTS: "Off-label" liraglutide treatment, licensed for type 2 diabetes treatment in children, was started as rescue therapy for protracted intractable diarrhea resulting in rapid improvement during the course of 12 months. CONCLUSION: Congenital GLP-1 deficiency was identified in patients with Mitchell-Riley syndrome. The favorable response to liraglutide further supports GLP-1 involvement in the pathogenesis of protracted diarrhea and its potential therapeutic use.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Nóbrega S, Monteiro MP, Pereira-da-Silva L, et al. Congenital Glucagon-like Peptide-1 Deficiency in the Pathogenesis of Protracted Diarrhea in Mitchell-Riley Syndrome. J Clin Endocrinol Metab. 2021. PMID: 33382423. doi:10.1210/clinem/dgaa916

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。